Clinical Trials Browser

OTHER × Hormone Receptor-positive Advanced Breast Cancer × Clear all

NCT05808582 2023-04-14

Chidamide Combined With Fulvestrant for HR+/HER2-advanced Breast Cancer

Phase 2 Unknown

Hormone Receptor-positive Advanced Breast Cancer

NCT05806047 2023-04-10

Combination of Chidamide and Fulvestrant for HR+/HER2- Breast Cancer That Has Failed Previous CDK4/6 i Adjuvant Therapy

Phase 2 Unknown

Hormone Receptor-positive Advanced Breast Cancer